Abstract: Provided herein are systems, methods and computer readable storage media for facilitating payments for consumer transactions and redemption of deal offerings. In providing such functionality, the system can be configured to, for example, receive payment for one or more products, determine a deal voucher's current value and cause the redemption of the deal voucher.

Abstract: The present invention relates to a catalyst for producing carbon nanotubes, a method for preparing the catalyst, and a method for producing carbon nanotubes using the catalyst which includes a support, and an active layer formed on a surface of the support, wherein the active layer contains CoO and Co3O4, and has, through XRD pattern measurement, one peak at 2?=35° to 38°, and one peak at 2?=41° to 44°, and a proportion of CoO among the CoO and Co3O4 is 55 at % or more. The catalyst according to the present invention can efficiently synthesize low-diameter carbon nanotubes.

Abstract: The present invention relates to a method for preparing a carbon nanotube-producing catalyst using chemical vapor deposition method. Using the above preparation method, a uniform and thin coating layer can be formed even on the surface of a support having a high-specific-surface-area having a 3D structure, and high-quality and low-diameter carbon nanotubes can be produced using the catalyst prepared through this method.

Abstract: The present invention relates to bundle-type carbon nanotubes having an average bundle thickness of 10 ?m or more, and a D50 of 10 ?m or more. The carbon nanotubes have excellent electrical conductivity and dispersibility and are particularly suitable for use as a conductive material.

Abstract: Drug-delivery systems such as drug-delivery stents having an anti-proliferative agent such as everolimus and an anti-flammatory agent such as clobetasol are provided. Also disclosed are methods of treating a vascular impairment such as restenosis or vulnerable plaque.

Abstract: A drug-delivery system is provided including at least 100 ?g of everolimus and clobetasol, such that the ratio of everolimus to clobetasol is at least 10:1 (w/w) or the amount of everolimus by weight is at least 10 times more than clobetasol. The system can be a stent. Also provided a method of treating restenosis or vulnerable plaque of a blood vessel, the method includes locally administering to a patient a first drug selected from a group consisting of rapamycin (sirolimus), Biolimus A9, deforolimus, AP23572, tacrolimus, temsirolimus, pimecrolimus, zotarolimus (ABT-578), 40-O-(2-hydroxy)ethylrapamycin (everolimus), 40-O-(3-hydroxy)propylrapamycin, 40-O-[2-(2-hydroxy)ethoxy]ethylrapamycin, 40-O-tetrazolylrapamycin and 40-epi-(N1-tetrazolyl)rapamycin, and locally administering to a patient a second drug consisting of clobetasol, wherein the minimum amount of the first drug that is locally administered is 100 ?g, and wherein the ratio of the first drug to the second drug is, for example, 10:1 to 100:1 (w/w).

Abstract: Drug-delivery stents capable of providing release of two or more drugs such as everolimus and estradiol are provided. The stents can be used for treating a disease such as restenosis and vulnerable plaque.

Abstract: A portable terminal and a method for displaying a preference item in the portable terminal that provides a distinguishing view of the preferential item(s). The method includes: displaying, upon receipt of a request to display an item list, the item list; checking, while searching the item list, whether a preference is set for an item to be displayed; and applying, if a preference is set for an item to be displayed, an event to the preference item and displaying the preference item. Applying an event to the preference item and displaying the preference item may include: determining the event that is set for the preference item, and applying the event to the preference item and displaying the preference item.

Abstract: A composite implantable device for promoting tissue ingrowth therein comprising a biodurable reticulated elastomeric matrix having a three-dimensional porous structure having a continueous network of interconnected and intercommunicating open pores and a support structure is disclosed. The support structure may be a polymeric surgical mesh comprising a plurality of intersecting one-dimensional reinforcement elements, wherein said mesh is affixed to a face of said first matrix. Methods of making and using the implantable device are also provided.

Abstract: A drug-delivery system is provided including at least 100 ?g of everolimus and clobetasol, such that the ratio of everolimus to clobetasol is at least 10:1 (w/w) or the amount of everolimus by weight is at least 10 times more than clobetasol. The system can be a stent. Also provided a method of treating restenosis or vulnerable plaque of a blood vessel, the method includes locally administering to a patient a first drug selected from a group consisting of rapamycin (sirolimus), Biolimus A9, deforolimus, AP23572, tacrolimus, temsirolimus, pimecrolimus, zotarolimus (ABT-578), 40-O-(2-hydroxy)ethylrapamycin (everolimus), 40-O-(3-hydroxy)propylrapamycin, 40-O-[2-(2-hydroxy)ethoxy]ethylrapamycin, 40-O-tetrazolylrapamycin and 40-epi-(N1-tetrazolyl)rapamycin, and locally administering to a patient a second drug consisting of clobetasol, wherein the minimum amount of the first drug that is locally administered is 100 ?g, and wherein the ratio of the first drug to the second drug is, for example, 10:1 to 100:1 (w/w).

Abstract: A portable terminal and a method for displaying a preference item in the portable terminal that provides a distinguishing view of the preferential item(s). The method includes: displaying, upon receipt of a request to display an item list, the item list; checking, while searching the item list, whether a preference is set for an item to be displayed; and applying, if a preference is set for an item to be displayed, an event to the preference item and displaying the preference item. Applying an event to the preference item and displaying the preference item may include: determining the event that is set for the preference item, and applying the event to the preference item and displaying the preference item.

Abstract: An implantable medical device including a polymer matrix containing everolimus and pimecrolimus, and methods of using the device for the treatment of vascular disease are disclosed.

Abstract: Drug-delivery stents capable of providing release of two or more drugs such as everolimus and estradiol are provided. The stents can be used for treating a disease such as restenosis and vulnerable plaque.

Abstract: Drug-delivery systems such as drug-delivery stents having an anti-proliferative agent such as everolimus and an anti-flammatory agent such as clobetasol are provided. Also disclosed are methods of treating a vascular impairment such as restenosis or vulnerable plaque.

Abstract: Drug-delivery systems such as drug-delivery stents having an anti-proliferative agent such as everolimus and an anti-flammatory agent such as clobetasol are provided. Also disclosed are methods of treating a vascular impairment such as restenosis or vulnerable plaque.

Abstract: Drug-delivery stents capable of providing release of two or more drugs such as everolimus and estradiol are provided. The stents can be used for treating a disease such as restenosis and vulnerable plaque.

Abstract: A cleaning pad for use on a cleaning system in which cleaning fluid or other liquid is dispensed onto a surface in front of a cleaning head portion, the cleaning pad comprising a central absorbent and scrubbing portion, a back edge portion for removably attaching the cleaning pad to the cleaning head portion, and a front edge portion for removably attaching the cleaning pad to the cleaning head portion, the front edge portion having a notch thereon, thereby allowing attachment of the cleaning pad to the cleaning head portion such that cleaning or other fluid can be dispensed from the cleaning head portion onto a surface in front of the cleaning head portion without interference by the cleaning pad.